We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| CNS Pharmaceuticals Inc | NASDAQ:CNSP | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.01 | -0.94% | 1.05 | 1.05 | 1.08 | 1.10 | 1.02 | 1.08 | 262,076 | 00:54:35 |
The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
|
| FORM C |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB APPROVAL |
| OMB Number: ####-#### Estimated average burden hours per response: ##.# |
| Name of Issuer: | CNS Pharmaceuticals, Inc. |
| Form: | Corporation |
| Jurisdiction of Incorporation/Organization: | NV |
| Date of Incorporation/Organization: | 07-27-2017 |
| Address 1: | 2100 WEST LOOP SOUTH |
| Address 2: | SUITE 900 |
| City: | HOUSTON |
| State/Country: | TX |
| Mailing Zip/Postal Code: | 77027 |
| Website of Issuer: | www.cnspharma.com |
| Issuer: | /s/ John Climaco |
| Signature: | John Climaco |
| Title: | Chief Executive Officer |
| Signature: | /s/ John Climaco |
| Title: | President, Chief Executive Officer and Director |
| Date: | 04-24-2020 |
| Signature: | /s/ Christopher Downs |
| Title: | Chief Financial Officer |
| Date: | 04-24-2020 |
| Signature: | /s/ Jerzy (George) Gumulka |
| Title: | Director |
| Date: | 04-24-2020 |
| Signature: | /s/ Carl Evans |
| Title: | Director |
| Date: | 04-24-2020 |
| Signature: | /s/ Jeffry Keyes |
| Title: | Director |
| Date: | 04-24-2020 |
| Signature: | /s/ Andrzej Andraczke | |
Title:
Your Recent History
It looks like you are not logged in. Click the button below to log in and keep track of your recent history. 
Get The App  Support: +44 (0) 203 8794 460 | support@advfn.com By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions |
Hot Features
Premium
